Medical Imaging Market - forecast to 2033 : By MODALITY (X-ray Systems, CT Scanners, MRI Systems, Ultrasound Systems, Nuclear Imaging Systems, Mammography Systems, Fluoroscopy Systems, Others), TECHNOLOGY (Digital Imaging, Analog Imaging, Portable Imaging

Medical Imaging Market - forecast to 2033 : By MODALITY (X-ray Systems, CT Scanners, MRI Systems, Ultrasound Systems, Nuclear Imaging Systems, Mammography Systems, Fluoroscopy Systems, Others), TECHNOLOGY (Digital Imaging, Analog Imaging, Portable Imaging, Tomosynthesis, Positron Emission Tomography, Single-Photon Emission Computed Tomography), IMAGE TYPE (2D Images, 3D Images, 4D Images), COMPONENT (Imaging Sensors, Detectors, Display Units, Image Processing Units, Contrast Agents), APPLICATION (Oncology, Cardiology, Neurology, Orthopedics, Gastroenterology, Gynecology, Urology, Pulmonology, Others), END-USER (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Research and Academic Institutes, Others), and Region


The Medical Imaging Market is an expansive and dynamic sector dedicated to advancing healthcare diagnostics through sophisticated imaging technologies. This market includes a variety of modalities such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear imaging, each offering distinct advantages in visualizing internal bodily structures for accurate diagnosis, treatment planning, and disease monitoring.

The Medical Imaging Market Market size was USD 40.33 Billion in 2023, and it is anticipated to grow to over 74.21 Billion by 2033, at a CAGR of over 6.3% during the forecast period.

A key driver of the Medical Imaging Market's growth is the rising prevalence of chronic diseases, which underscores the need for early detection and ongoing monitoring. The expanding global aging population and increasing healthcare expenditures further amplify the demand for medical imaging services. Technological advancements, such as the integration of artificial intelligence and machine learning, are enhancing image quality and diagnostic accuracy, thereby fueling market expansion. Additionally, the widespread use of medical imaging systems in hospitals, diagnostic centers, and specialty clinics, along with the ongoing integration of picture archiving and communication systems (PACS) and electronic medical records (EMR), is streamlining workflows and boosting healthcare efficiency. Emerging trends, including portable and handheld devices and advancements in molecular imaging, are extending the reach of diagnostics and opening new avenues for personalized medicine, making medical imaging an essential and evolving component of modern healthcare.

Key Trends:
  • Enhanced Focus on AI Integration: The integration of Artificial Intelligence in medical imaging systems is revolutionizing the way diagnoses are conducted, offering predictive analytics and improved accuracy.
  • Rise of Portable Imaging Devices: A surge in demand for portable and compact imaging systems is evident, catering to the need for point-of-care diagnostics and telemedicine applications.
  • Expansion in Molecular Imaging: Advancements in molecular imaging are providing deeper insights into cellular and molecular functions, paving the way for personalized medicine.
  • Increased Adoption of Hybrid Imaging Systems: There is a growing preference for hybrid systems combining different imaging modalities, such as PET/CT and SPECT/CT, to provide comprehensive diagnostic information.
  • Growing Importance of 3D Imaging: Three-dimensional imaging technologies are increasingly preferred for their detailed visualization capabilities, aiding in complex surgical planning and procedures.
Key Drivers:
  • Technological Advancements: Continuous innovation in medical imaging technologies, such as AI integration and 3D imaging, enhances diagnostic precision and broadens application scope.
  • Aging Population: The growing demographic of elderly individuals worldwide increases the prevalence of chronic diseases, thereby escalating the demand for medical imaging services.
  • Healthcare Expenditure: An upsurge in healthcare spending, particularly in developed and emerging economies, correlates with greater investments in medical imaging facilities.
  • Regulatory Approvals: Expedited and streamlined regulatory processes for medical devices contribute to the quicker introduction of advanced imaging systems into the market.
  • Increase in Non-invasive Procedures: The rising preference for non-invasive diagnostic procedures among patients and healthcare providers is bolstering the adoption of medical imaging modalities.
Restraints and Challenges:
  • Regulatory and Reimbursement Hurdles: Stricter regulations and complex reimbursement scenarios pose significant challenges, slowing down the adoption of new imaging technologies.
  • High Cost of Imaging Equipment: The substantial investment required for advanced medical imaging systems can be a deterrent for healthcare facilities, especially in cost-sensitive markets.
  • Cybersecurity Concerns: With increasing digitization, the vulnerability of medical imaging devices to cyberattacks is a major concern, affecting market confidence and growth.
  • Technological Complexity and Maintenance: The complexity of emerging imaging technologies demands specialized technical expertise for operation and maintenance, limiting widespread adoption across smaller institutions.
  • Market Saturation in Developed Countries: The high penetration of medical imaging systems in developed countries leads to a slower growth rate, as replacement cycles are longer and incremental innovations are often not sufficient to trigger new purchases.
Segmentation:

MODALITY (X-Ray Systems, CT Scanners, MRI Systems, Ultrasound Systems, Nuclear Imaging Systems, Mammography Systems, Fluoroscopy Systems, Others), TECHNOLOGY (Digital Imaging, Analog Imaging, Portable Imaging, Tomosynthesis, Positron Emission Tomography, Single-Photon Emission Computed Tomography), IMAGE TYPE (2D Images, 3D Images, 4D Images), COMPONENT (Imaging Sensors, Detectors, Display Units, Image Processing Units, Contrast Agents), APPLICATION (Oncology, Cardiology, Neurology, Orthopedics, Gastroenterology, Gynecology, Urology, Pulmonology, Others), END-USER (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Research And Academic Institutes, Others), And Region

Key Players:

The Medical Imaging Market includes players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Hitachi Medical Corporation, Fujifilm Holdings Corporation, Samsung Medison, Shimadzu Corporation, Hologic, Agfa-Gevaert Group, Carestream Health, Mindray Medical International, Konica Minolta Healthcare, Esaote, Sectra AB, Planmed, Analogic Corporation, United Imaging Healthcare, Optos Plc, and Curium Pharma, among others.

Value Chain Analysis:

The value chain analysis for the Medical Imaging Market encompasses the following stages: Raw Material Procurement, R&D, Product Approval, Large Scale Manufacturing, and Sales and Marketing. Each stage is pivotal to ensuring the seamless delivery of high-quality medical imaging solutions to the market. Below is an in-depth examination of each stage:
  • Raw Material Procurement: Identify sources of essential raw materials, such as high-grade silicon, rare earth metals, and other specialized components critical for medical imaging devices. Assess the availability, quality, and sustainability of these materials. Understanding market dynamics, pricing trends, and potential risks associated with sourcing materials is crucial to maintaining a stable supply chain and minimizing production disruptions.
  • R&D: Focus on market analysis, trend forecasting, feasibility studies, and conducting experiments to develop innovative imaging technologies. This includes enhancing existing products, improving image resolution, reducing radiation exposure, and integrating AI for advanced diagnostics. Collaboration with academic institutions, research labs, and industry experts is imperative for staying at the forefront of technological advancements.
  • Product Approval: Navigate the complex landscape of legal requirements, industry regulations, and certification processes. This involves rigorous testing of products for safety, efficacy, and environmental impact. Securing approvals from regulatory bodies such as the FDA, EMA, and other international health authorities is essential to ensure compliance and facilitate market entry.
  • Large Scale Manufacturing: Optimize production processes to enhance efficiency and reduce costs. This includes adopting process engineering, automation technologies, and robust supply chain management practices. Ensuring high standards of quality control and implementing lean manufacturing principles are vital to maintaining product integrity and meeting the demands of a growing market.
  • Sales and Marketing: Understand customer needs, market trends, and the competitive landscape to effectively position products in the market. This involves market segmentation, consumer behavior analysis, and the development of compelling branding strategies. Leveraging digital marketing, strategic partnerships, and targeted outreach campaigns can drive product adoption and expand market share.
Research Scope:
  • Estimates and forecast the overall market size for the total market, across type, application, and region
  • Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
  • Identify factors influencing market growth and challenges, opportunities, drivers, and restraints
  • Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
  • Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
  • Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
  • To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements
  • Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives.
Our research report offers comprehensive deep segmental analysis, local competitive insights, and market positioning tailored to your needs. It includes detailed local market analysis and company analysis, alongside SWOT assessments to identify strengths, weaknesses, opportunities, and threats. The report is enhanced with an Excel data dashboard for seamless analytics and efficient data crunching, providing a user-friendly interface for in-depth examination. This robust toolkit empowers businesses to make informed decisions, stay ahead of competitors, and strategically position themselves in the market.”

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.


1.0: MARKET DEFINITION
1.1: MARKET SEGMENTATION
1.2: MARKET SEGMENTATION
1.3: REGIONAL COVERAGE
1.4: KEY COMPANY PROFILES
1.5: OTHER KEY PROFILES
1.6: DATA SNAPSHOT
2.0: SUMMARY
2.1: SUMMARY
2.2: KEY OPINION LEADERS
2.3: KEY HIGHLIGHTS BY MODALITY
2.4: KEY HIGHLIGHTS BY TECHNOLOGY
2.5: KEY HIGHLIGHTS BY IMAGE TYPE
2.6: KEY HIGHLIGHTS BY COMPONENT
2.7: KEY HIGHLIGHTS BY APPLICATION
2.8: KEY HIGHLIGHTS BY END-USER
2.9: KEY HIGHLIGHTS BY REGION
2.10: KEY HIGHLIGHTS BY NORTH AMERICA
2.11: KEY HIGHLIGHTS BY LATIN AMERICA
2.12: KEY HIGHLIGHTS BY EUROPE
2.13: KEY HIGHLIGHTS BY ASIA-PACIFIC
2.14: KEY HIGHLIGHTS BY MIDDLE EAST AFRICA
3.0: MARKET ATTRACTIVENESS ANALYSIS BY MODALITY
3.1: MARKET ATTRACTIVENESS ANALYSIS BY TECHNOLOGY
3.2: MARKET ATTRACTIVENESS ANALYSIS BY IMAGE TYPE
3.3: MARKET ATTRACTIVENESS ANALYSIS BY COMPONENT
3.4: MARKET ATTRACTIVENESS ANALYSIS BY APPLICATION
3.5: MARKET ATTRACTIVENESS ANALYSIS BY END-USER
3.6: MARKET ATTRACTIVENESS ANALYSIS BY REGION
3.7: MARKET ATTRACTIVENESS ANALYSIS BY COUNTRY
4.0: MARKET TRENDS
4.1: MARKET DRIVERS
4.2: MARKET OPPORTUNITIES
4.3: MARKET RESTRAINTS
4.4: MARKET THREATS
4.5: IMPACT ANALYSIS
5.0: PORTERS FIVE FORCES
5.1: ANSOFF MATRIX
5.2: PESTLE ANALYSIS
5.3: VALUE CHAIN ANALYSIS
6.0: IMPACT OF COVID-19 ON MARKET
7.0: IMPACT OF RUSSIA-UKRAINE WAR
8.0: PARENT MARKET ANALYSIS
8.1: REGULATORY LANDSCAPE
8.2: PRICING ANALYSIS
8.3: DEMAND SUPPLY ANALYSIS
8.4: DEMAND SUPPLY ANALYSIS
8.5: CONSUMER BUYING INTEREST
8.6: CONSUMER BUYING INTEREST
8.7: SUPPLY CHAIN ANALYSIS
8.8: COMPETITION PRODUCT ANALYSIS BY MANUFACTURER
8.9: TECHNOLOGICAL ADVANCEMENTS
8.10: RECENT DEVELOPMENTS
8.11: CASE STUDIES
9.0: MARKET SIZE AND FORECAST – BY VALUE (US$ MILLION)
9.1: MARKET SIZE AND FORECAST – BY VOLUME (UNITS)
10.0: MODALITY OVERVIEW
10.1: MARKET SIZE AND FORECAST – BY MODALITY
10.2: X-RAY SYSTEMS OVERVIEW
10.3: X-RAY SYSTEMS BY REGION
10.4: X-RAY SYSTEMS BY COUNTRY
10.5: CT SCANNERS OVERVIEW
10.6: CT SCANNERS BY REGION
10.7: CT SCANNERS BY COUNTRY
10.8: MRI SYSTEMS OVERVIEW
10.9: MRI SYSTEMS BY REGION
10.10: MRI SYSTEMS BY COUNTRY
10.11: ULTRASOUND SYSTEMS OVERVIEW
10.12: ULTRASOUND SYSTEMS BY REGION
10.13: ULTRASOUND SYSTEMS BY COUNTRY
10.14: NUCLEAR IMAGING SYSTEMS OVERVIEW
10.15: NUCLEAR IMAGING SYSTEMS BY REGION
10.16: NUCLEAR IMAGING SYSTEMS BY COUNTRY
10.17: MAMMOGRAPHY SYSTEMS OVERVIEW
10.18: MAMMOGRAPHY SYSTEMS BY REGION
10.19: MAMMOGRAPHY SYSTEMS BY COUNTRY
10.20: FLUOROSCOPY SYSTEMS OVERVIEW
10.21: FLUOROSCOPY SYSTEMS BY REGION
10.22: FLUOROSCOPY SYSTEMS BY COUNTRY
10.23: OTHERS OVERVIEW
10.24: OTHERS BY REGION
10.25: OTHERS BY COUNTRY
11.0: TECHNOLOGY OVERVIEW
11.1: MARKET SIZE AND FORECAST – BY TECHNOLOGY
11.2: DIGITAL IMAGING OVERVIEW
11.3: DIGITAL IMAGING BY REGION
11.4: DIGITAL IMAGING BY COUNTRY
11.5: ANALOG IMAGING OVERVIEW
11.6: ANALOG IMAGING BY REGION
11.7: ANALOG IMAGING BY COUNTRY
11.8: PORTABLE IMAGING OVERVIEW
11.9: PORTABLE IMAGING BY REGION
11.10: PORTABLE IMAGING BY COUNTRY
11.11: TOMOSYNTHESIS OVERVIEW
11.12: TOMOSYNTHESIS BY REGION
11.13: TOMOSYNTHESIS BY COUNTRY
11.14: POSITRON EMISSION TOMOGRAPHY OVERVIEW
11.15: POSITRON EMISSION TOMOGRAPHY BY REGION
11.16: POSITRON EMISSION TOMOGRAPHY BY COUNTRY
11.17: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY OVERVIEW
11.18: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY BY REGION
11.19: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY BY COUNTRY
12.0: IMAGE TYPE OVERVIEW
12.1: MARKET SIZE AND FORECAST – BY IMAGE TYPE
12.2: 2D IMAGES OVERVIEW
12.3: 2D IMAGES BY REGION
12.4: 2D IMAGES BY COUNTRY
12.5: 3D IMAGES OVERVIEW
12.6: 3D IMAGES BY REGION
12.7: 3D IMAGES BY COUNTRY
12.8: 4D IMAGES OVERVIEW
12.9: 4D IMAGES BY REGION
12.10: 4D IMAGES BY COUNTRY
13.0: COMPONENT OVERVIEW
13.1: MARKET SIZE AND FORECAST – BY COMPONENT
13.2: IMAGING SENSORS OVERVIEW
13.3: IMAGING SENSORS BY REGION
13.4: IMAGING SENSORS BY COUNTRY
13.5: DETECTORS OVERVIEW
13.6: DETECTORS BY REGION
13.7: DETECTORS BY COUNTRY
13.8: DISPLAY UNITS OVERVIEW
13.9: DISPLAY UNITS BY REGION
13.10: DISPLAY UNITS BY COUNTRY
13.11: IMAGE PROCESSING UNITS OVERVIEW
13.12: IMAGE PROCESSING UNITS BY REGION
13.13: IMAGE PROCESSING UNITS BY COUNTRY
13.14: CONTRAST AGENTS OVERVIEW
13.15: CONTRAST AGENTS BY REGION
13.16: CONTRAST AGENTS BY COUNTRY
14.0: APPLICATION OVERVIEW
14.1: MARKET SIZE AND FORECAST – BY APPLICATION
14.2: ONCOLOGY OVERVIEW
14.3: ONCOLOGY BY REGION
14.4: ONCOLOGY BY COUNTRY
14.5: CARDIOLOGY OVERVIEW
14.6: CARDIOLOGY BY REGION
14.7: CARDIOLOGY BY COUNTRY
14.8: NEUROLOGY OVERVIEW
14.9: NEUROLOGY BY REGION
14.10: NEUROLOGY BY COUNTRY
14.11: ORTHOPEDICS OVERVIEW
14.12: ORTHOPEDICS BY REGION
14.13: ORTHOPEDICS BY COUNTRY
14.14: GASTROENTEROLOGY OVERVIEW
14.15: GASTROENTEROLOGY BY REGION
14.16: GASTROENTEROLOGY BY COUNTRY
14.17: GYNECOLOGY OVERVIEW
14.18: GYNECOLOGY BY REGION
14.19: GYNECOLOGY BY COUNTRY
14.20: UROLOGY OVERVIEW
14.21: UROLOGY BY REGION
14.22: UROLOGY BY COUNTRY
14.23: PULMONOLOGY OVERVIEW
14.24: PULMONOLOGY BY REGION
14.25: PULMONOLOGY BY COUNTRY
14.26: OTHERS OVERVIEW
14.27: OTHERS BY REGION
14.28: OTHERS BY COUNTRY
15.0: END-USER OVERVIEW
15.1: MARKET SIZE AND FORECAST – BY END-USER
15.2: HOSPITALS OVERVIEW
15.3: HOSPITALS BY REGION
15.4: HOSPITALS BY COUNTRY
15.5: DIAGNOSTIC IMAGING CENTERS OVERVIEW
15.6: DIAGNOSTIC IMAGING CENTERS BY REGION
15.7: DIAGNOSTIC IMAGING CENTERS BY COUNTRY
15.8: AMBULATORY SURGICAL CENTERS OVERVIEW
15.9: AMBULATORY SURGICAL CENTERS BY REGION
15.10: AMBULATORY SURGICAL CENTERS BY COUNTRY
15.11: RESEARCH AND ACADEMIC INSTITUTES OVERVIEW
15.12: RESEARCH AND ACADEMIC INSTITUTES BY REGION
15.13: RESEARCH AND ACADEMIC INSTITUTES BY COUNTRY
15.14: OTHERS OVERVIEW
15.15: OTHERS BY REGION
15.16: OTHERS BY COUNTRY
16.0: REGION OVERVIEW
16.1: MARKET SIZE AND FORECAST - BY REGION
16.2: NORTH AMERICA OVERVIEW
16.3: NORTH AMERICA BY COUNTRY
16.4: UNITED STATES OVERVIEW
16.5: UNITED STATES OVERVIEW
16.6: UNITED STATES OVERVIEW
16.7: UNITED STATES OVERVIEW
16.8: UNITED STATES OVERVIEW
16.9: UNITED STATES OVERVIEW
16.10: UNITED STATES OVERVIEW
16.11: LOCAL MARKET ANALYSIS - UNITED STATES
16.12: COMPETITIVE ANALYSIS - UNITED STATES
16.13: CANADA OVERVIEW
16.14: CANADA OVERVIEW
16.15: CANADA OVERVIEW
16.16: CANADA OVERVIEW
16.17: CANADA OVERVIEW
16.18: CANADA OVERVIEW
16.19: CANADA OVERVIEW
16.20: LOCAL MARKET ANALYSIS - CANADA
16.21: COMPETITIVE ANALYSIS - CANADA
16.22: LATIN AMERICA OVERVIEW
16.23: LATIN AMERICA BY COUNTRY
16.24: MEXICO OVERVIEW
16.25: MEXICO OVERVIEW
16.26: MEXICO OVERVIEW
16.27: MEXICO OVERVIEW
16.28: MEXICO OVERVIEW
16.29: MEXICO OVERVIEW
16.30: MEXICO OVERVIEW
16.31: LOCAL MARKET ANALYSIS - MEXICO
16.32: COMPETITIVE ANALYSIS - MEXICO
16.33: BRAZIL OVERVIEW
16.34: BRAZIL OVERVIEW
16.35: BRAZIL OVERVIEW
16.36: BRAZIL OVERVIEW
16.37: BRAZIL OVERVIEW
16.38: BRAZIL OVERVIEW
16.39: BRAZIL OVERVIEW
16.40: LOCAL MARKET ANALYSIS - BRAZIL
16.41: COMPETITIVE ANALYSIS - BRAZIL
16.42: ARGENTINA OVERVIEW
16.43: ARGENTINA OVERVIEW
16.44: ARGENTINA OVERVIEW
16.45: ARGENTINA OVERVIEW
16.46: ARGENTINA OVERVIEW
16.47: ARGENTINA OVERVIEW
16.48: ARGENTINA OVERVIEW
16.49: LOCAL MARKET ANALYSIS - ARGENTINA
16.50: COMPETITIVE ANALYSIS - ARGENTINA
16.51: REST OF LATAM OVERVIEW
16.52: REST OF LATAM OVERVIEW
16.53: REST OF LATAM OVERVIEW
16.54: REST OF LATAM OVERVIEW
16.55: REST OF LATAM OVERVIEW
16.56: REST OF LATAM OVERVIEW
16.57: REST OF LATAM OVERVIEW
16.58: LOCAL MARKET ANALYSIS - REST OF LATAM
16.59: COMPETITIVE ANALYSIS - REST OF LATAM
16.60: EUROPE OVERVIEW
16.61: EUROPE BY COUNTRY
16.62: GERMANY OVERVIEW
16.63: GERMANY OVERVIEW
16.64: GERMANY OVERVIEW
16.65: GERMANY OVERVIEW
16.66: GERMANY OVERVIEW
16.67: GERMANY OVERVIEW
16.68: GERMANY OVERVIEW
16.69: LOCAL MARKET ANALYSIS - GERMANY
16.70: COMPETITIVE ANALYSIS - GERMANY
16.71: FRANCE OVERVIEW
16.72: FRANCE OVERVIEW
16.73: FRANCE OVERVIEW
16.74: FRANCE OVERVIEW
16.75: FRANCE OVERVIEW
16.76: FRANCE OVERVIEW
16.77: FRANCE OVERVIEW
16.78: LOCAL MARKET ANALYSIS - FRANCE
16.79: COMPETITIVE ANALYSIS - FRANCE
16.80: UNITED KINGDOM OVERVIEW
16.81: UNITED KINGDOM OVERVIEW
16.82: UNITED KINGDOM OVERVIEW
16.83: UNITED KINGDOM OVERVIEW
16.84: UNITED KINGDOM OVERVIEW
16.85: UNITED KINGDOM OVERVIEW
16.86: UNITED KINGDOM OVERVIEW
16.87: LOCAL MARKET ANALYSIS - UNITED KINGDOM
16.88: COMPETITIVE ANALYSIS - UNITED KINGDOM
16.89: RUSSIA OVERVIEW
16.90: RUSSIA OVERVIEW
16.91: RUSSIA OVERVIEW
16.92: RUSSIA OVERVIEW
16.93: RUSSIA OVERVIEW
16.94: RUSSIA OVERVIEW
16.95: RUSSIA OVERVIEW
16.96: LOCAL MARKET ANALYSIS - RUSSIA
16.97: COMPETITIVE ANALYSIS - RUSSIA
16.98: SPAIN OVERVIEW
16.99: SPAIN OVERVIEW
16.100: SPAIN OVERVIEW
16.101: SPAIN OVERVIEW
16.102: SPAIN OVERVIEW
16.103: SPAIN OVERVIEW
16.104: SPAIN OVERVIEW
16.105: LOCAL MARKET ANALYSIS - SPAIN
16.106: COMPETITIVE ANALYSIS - SPAIN
16.107: ITALY OVERVIEW
16.108: ITALY OVERVIEW
16.109: ITALY OVERVIEW
16.110: ITALY OVERVIEW
16.111: ITALY OVERVIEW
16.112: ITALY OVERVIEW
16.113: ITALY OVERVIEW
16.114: LOCAL MARKET ANALYSIS - ITALY
16.115: COMPETITIVE ANALYSIS - ITALY
16.116: NETHERLANDS OVERVIEW
16.117: NETHERLANDS OVERVIEW
16.118: NETHERLANDS OVERVIEW
16.119: NETHERLANDS OVERVIEW
16.120: NETHERLANDS OVERVIEW
16.121: NETHERLANDS OVERVIEW
16.122: NETHERLANDS OVERVIEW
16.123: LOCAL MARKET ANALYSIS - NETHERLANDS
16.124: COMPETITIVE ANALYSIS - NETHERLANDS
16.125: ISRAEL OVERVIEW
16.126: ISRAEL OVERVIEW
16.127: ISRAEL OVERVIEW
16.128: ISRAEL OVERVIEW
16.129: ISRAEL OVERVIEW
16.130: ISRAEL OVERVIEW
16.131: ISRAEL OVERVIEW
16.132: LOCAL MARKET ANALYSIS - ISRAEL
16.133: COMPETITIVE ANALYSIS - ISRAEL
16.134: TURKEY OVERVIEW
16.135: TURKEY OVERVIEW
16.136: TURKEY OVERVIEW
16.137: TURKEY OVERVIEW
16.138: TURKEY OVERVIEW
16.139: TURKEY OVERVIEW
16.140: TURKEY OVERVIEW
16.141: LOCAL MARKET ANALYSIS - TURKEY
16.142: COMPETITIVE ANALYSIS - TURKEY
16.143: REST OF EUROPE OVERVIEW
16.144: REST OF EUROPE OVERVIEW
16.145: REST OF EUROPE OVERVIEW
16.146: REST OF EUROPE OVERVIEW
16.147: REST OF EUROPE OVERVIEW
16.148: REST OF EUROPE OVERVIEW
16.149: REST OF EUROPE OVERVIEW
16.150: LOCAL MARKET ANALYSIS - REST OF EUROPE
16.151: COMPETITIVE ANALYSIS - REST OF EUROPE
16.152: ASIA-PACIFIC OVERVIEW
16.153: ASIA-PACIFIC BY COUNTRY
16.154: CHINA OVERVIEW
16.155: CHINA OVERVIEW
16.156: CHINA OVERVIEW
16.157: CHINA OVERVIEW
16.158: CHINA OVERVIEW
16.159: CHINA OVERVIEW
16.160: CHINA OVERVIEW
16.161: LOCAL MARKET ANALYSIS - CHINA
16.162: COMPETITIVE ANALYSIS - CHINA
16.163: INDIA OVERVIEW
16.164: INDIA OVERVIEW
16.165: INDIA OVERVIEW
16.166: INDIA OVERVIEW
16.167: INDIA OVERVIEW
16.168: INDIA OVERVIEW
16.169: INDIA OVERVIEW
16.170: LOCAL MARKET ANALYSIS - INDIA
16.171: COMPETITIVE ANALYSIS - INDIA
16.172: JAPAN OVERVIEW
16.173: JAPAN OVERVIEW
16.174: JAPAN OVERVIEW
16.175: JAPAN OVERVIEW
16.176: JAPAN OVERVIEW
16.177: JAPAN OVERVIEW
16.178: JAPAN OVERVIEW
16.179: LOCAL MARKET ANALYSIS - JAPAN
16.180: COMPETITIVE ANALYSIS - JAPAN
16.181: AUSTRALIA OVERVIEW
16.182: AUSTRALIA OVERVIEW
16.183: AUSTRALIA OVERVIEW
16.184: AUSTRALIA OVERVIEW
16.185: AUSTRALIA OVERVIEW
16.186: AUSTRALIA OVERVIEW
16.187: AUSTRALIA OVERVIEW
16.188: LOCAL MARKET ANALYSIS - AUSTRALIA
16.189: COMPETITIVE ANALYSIS - AUSTRALIA
16.190: INDONESIA OVERVIEW
16.191: INDONESIA OVERVIEW
16.192: INDONESIA OVERVIEW
16.193: INDONESIA OVERVIEW
16.194: INDONESIA OVERVIEW
16.195: INDONESIA OVERVIEW
16.196: INDONESIA OVERVIEW
16.197: LOCAL MARKET ANALYSIS - INDONESIA
16.198: COMPETITIVE ANALYSIS - INDONESIA
16.199: MALAYSIA OVERVIEW
16.200: MALAYSIA OVERVIEW
16.201: MALAYSIA OVERVIEW
16.202: MALAYSIA OVERVIEW
16.203: MALAYSIA OVERVIEW
16.204: MALAYSIA OVERVIEW
16.205: MALAYSIA OVERVIEW
16.206: LOCAL MARKET ANALYSIS - MALAYSIA
16.207: COMPETITIVE ANALYSIS - MALAYSIA
16.208: REST OF APAC OVERVIEW
16.209: REST OF APAC OVERVIEW
16.210: REST OF APAC OVERVIEW
16.211: REST OF APAC OVERVIEW
16.212: REST OF APAC OVERVIEW
16.213: REST OF APAC OVERVIEW
16.214: REST OF APAC OVERVIEW
16.215: LOCAL MARKET ANALYSIS - REST OF APAC
16.216: COMPETITIVE ANALYSIS - REST OF APAC
16.217: MIDDLE EAST AFRICA OVERVIEW
16.218: MIDDLE EAST AFRICA BY COUNTRY
16.219: SAUDI ARABIA OVERVIEW
16.220: SAUDI ARABIA OVERVIEW
16.221: SAUDI ARABIA OVERVIEW
16.222: SAUDI ARABIA OVERVIEW
16.223: SAUDI ARABIA OVERVIEW
16.224: SAUDI ARABIA OVERVIEW
16.225: SAUDI ARABIA OVERVIEW
16.226: LOCAL MARKET ANALYSIS - SAUDI ARABIA
16.227: COMPETITIVE ANALYSIS - SAUDI ARABIA
16.228: UAE OVERVIEW
16.229: UAE OVERVIEW
16.230: UAE OVERVIEW
16.231: UAE OVERVIEW
16.232: UAE OVERVIEW
16.233: UAE OVERVIEW
16.234: UAE OVERVIEW
16.235: LOCAL MARKET ANALYSIS - UAE
16.236: COMPETITIVE ANALYSIS - UAE
16.237: SOUTH AFRICA OVERVIEW
16.238: SOUTH AFRICA OVERVIEW
16.239: SOUTH AFRICA OVERVIEW
16.240: SOUTH AFRICA OVERVIEW
16.241: SOUTH AFRICA OVERVIEW
16.242: SOUTH AFRICA OVERVIEW
16.243: SOUTH AFRICA OVERVIEW
16.244: LOCAL MARKET ANALYSIS - SOUTH AFRICA
16.245: COMPETITIVE ANALYSIS - SOUTH AFRICA
16.246: IRAN OVERVIEW
16.247: IRAN OVERVIEW
16.248: IRAN OVERVIEW
16.249: IRAN OVERVIEW
16.250: IRAN OVERVIEW
16.251: IRAN OVERVIEW
16.252: IRAN OVERVIEW
16.253: LOCAL MARKET ANALYSIS - IRAN
16.254: COMPETITIVE ANALYSIS - IRAN
16.255: QATAR OVERVIEW
16.256: QATAR OVERVIEW
16.257: QATAR OVERVIEW
16.258: QATAR OVERVIEW
16.259: QATAR OVERVIEW
16.260: QATAR OVERVIEW
16.261: QATAR OVERVIEW
16.262: LOCAL MARKET ANALYSIS - QATAR
16.263: COMPETITIVE ANALYSIS - QATAR
16.264: REST OF MEA OVERVIEW
16.265: REST OF MEA OVERVIEW
16.266: REST OF MEA OVERVIEW
16.267: REST OF MEA OVERVIEW
16.268: REST OF MEA OVERVIEW
16.269: REST OF MEA OVERVIEW
16.270: REST OF MEA OVERVIEW
16.271: LOCAL MARKET ANALYSIS - REST OF MEA
16.272: COMPETITIVE ANALYSIS - REST OF MEA
17.0: COMPETITION OVERVIEW
17.1: MARKET SHARE ANALYSIS
17.2: MARKET REVENUE BY KEY COMPANIES
17.3: MARKET POSITIONING
17.4: VENDORS BENCHMARKING
17.5: STRATEGY BENCHMARKING
17.6: STRATEGY BENCHMARKING
18.0: Siemens Healthineers
18.1: Siemens Healthineers
18.2: Siemens Healthineers
18.3: Siemens Healthineers
18.4: Siemens Healthineers
18.5: GE Healthcare
18.6: GE Healthcare
18.7: GE Healthcare
18.8: GE Healthcare
18.9: GE Healthcare
18.10: Philips Healthcare
18.11: Philips Healthcare
18.12: Philips Healthcare
18.13: Philips Healthcare
18.14: Philips Healthcare
18.15: Canon Medical Systems
18.16: Canon Medical Systems
18.17: Canon Medical Systems
18.18: Canon Medical Systems
18.19: Canon Medical Systems
18.20: Hitachi Medical Corporation
18.21: Hitachi Medical Corporation
18.22: Hitachi Medical Corporation
18.23: Hitachi Medical Corporation
18.24: Hitachi Medical Corporation
18.25: Fujifilm Holdings Corporation
18.26: Fujifilm Holdings Corporation
18.27: Fujifilm Holdings Corporation
18.28: Fujifilm Holdings Corporation
18.29: Fujifilm Holdings Corporation
18.30: Samsung Medison
18.31: Samsung Medison
18.32: Samsung Medison
18.33: Samsung Medison
18.34: Samsung Medison
18.35: Shimadzu Corporation
18.36: Shimadzu Corporation
18.37: Shimadzu Corporation
18.38: Shimadzu Corporation
18.39: Shimadzu Corporation
18.40: Hologic
18.41: Hologic
18.42: Hologic
18.43: Hologic
18.44: Hologic
18.45: Agfa-Gevaert Group
18.46: Agfa-Gevaert Group
18.47: Agfa-Gevaert Group
18.48: Agfa-Gevaert Group
18.49: Agfa-Gevaert Group
18.50: Carestream Health
18.51: Carestream Health
18.52: Carestream Health
18.53: Carestream Health
18.54: Carestream Health
18.55: Mindray Medical International
18.56: Mindray Medical International
18.57: Mindray Medical International
18.58: Mindray Medical International
18.59: Mindray Medical International
18.60: Konica Minolta Healthcare
18.61: Konica Minolta Healthcare
18.62: Konica Minolta Healthcare
18.63: Konica Minolta Healthcare
18.64: Konica Minolta Healthcare
18.65: Esaote
18.66: Esaote
18.67: Esaote
18.68: Esaote
18.69: Esaote
18.70: Sectra AB
18.71: Sectra AB
18.72: Sectra AB
18.73: Sectra AB
18.74: Sectra AB
18.75: Planmed
18.76: Planmed
18.77: Planmed
18.78: Planmed
18.79: Planmed
18.80: Analogic Corporation
18.81: Analogic Corporation
18.82: Analogic Corporation
18.83: Analogic Corporation
18.84: Analogic Corporation
18.85: United Imaging Healthcare
18.86: United Imaging Healthcare
18.87: United Imaging Healthcare
18.88: United Imaging Healthcare
18.89: United Imaging Healthcare
18.90: Optos Plc
18.91: Optos Plc
18.92: Optos Plc
18.93: Optos Plc
18.94: Optos Plc
18.95: Curium Pharma
18.96: Curium Pharma
18.97: Curium Pharma
18.98: Curium Pharma
18.99: Curium Pharma
580})

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings